AnnieGuard

Curated by Signal

AI based platform offering sarcoma risk assessment tool

Overview

AI based platform offering sarcoma risk assessment tool. It aims to enhance the evaluation process for healthcare providers by delivering real time insights into patient risk profiles and facilitating early detection of sarcoma. It utilizes artificial intelligence algorithms to analyze individual health data, including personal and family medical histories, to assess the risk of developing sarcoma.

Key facts

Founded: 2024
Headquarters: Washington, DC, United States
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Normal X
Provider of a learning app app for X-ray reference
Health TechnologyUnited States
LigoLab
LIS for anatomical pathology workflow
Health TechnologyGlendale, United States
Dexter Solutions
A provider of end to end solutions for small to medium medical practices
Health TechnologyWarrenville, United States

About AnnieGuard

What does AnnieGuard do?

AI based platform offering sarcoma risk assessment tool.

Where is AnnieGuard headquartered?

AnnieGuard is headquartered in Washington, DC, United States.

When was AnnieGuard founded?

AnnieGuard was founded in 2024.

Which sector is AnnieGuard in?

AnnieGuard operates in Health Technology.

Who are AnnieGuard's competitors?

Companies similar to AnnieGuard include Normal X, LigoLab, and Dexter Solutions.